Multimodal Cancer Therapy And Accelerated Brain Aging: Mechanisms, Biomarkers, And Clinical Consequences

Aging Theory
Aging Pathway
Clock
Cancer treatments, while life-saving, can lead to long-term cognitive and neurological problems often referred to as “chemobrain,” which is increasingly understood as an acceleration of the brain’s natural aging process.
Author

Gemini

Published

March 2, 2026

Many individuals who undergo cancer treatment experience lasting cognitive and neurological challenges, commonly known as “chemobrain.” These issues can include difficulties with memory, attention, processing speed, and even mood changes and fatigue. While previously thought to be temporary side effects, a growing body of evidence suggests that these problems are actually a result of cancer therapies accelerating the biological aging of the brain.

Researchers have identified several key mechanisms through which these treatments contribute to accelerated brain aging. These include oxidative stress, which is damage to cells caused by unstable molecules; neuroinflammation, which is inflammation within the brain; dysfunction of the blood-brain barrier, a protective shield that controls what enters the brain; mitochondrial impairment, affecting the energy-producing parts of cells; cellular senescence, where cells stop dividing and accumulate; and epigenetic remodeling, changes in how genes are expressed without altering the DNA sequence itself. These processes are similar to those seen in natural brain aging.

To better understand and address these effects, scientists are looking at various indicators. These include molecular biomarkers found in the blood, such as inflammatory substances and markers of cellular aging, as well as changes in epigenetic age, which is a measure of biological age based on DNA modifications. Advanced brain imaging techniques, like MRI, also reveal structural and functional alterations in the brains of cancer survivors, such as thinning of the brain’s outer layer and changes in white matter.

By recognizing these cognitive issues as a form of accelerated brain aging, medical professionals can improve how they identify individuals at risk, develop better diagnostic tools, and create more personalized care plans to help survivors manage and potentially mitigate these long-term effects.


Source: link to paper